Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Net Margin: 2020-2022

  • SELLAS Life Sciences Group's Net Margin fell 163134.00% to -1,673.50% in Q1 2022 from the same period last year, while for Mar 2022 it was -333.63%, marking a year-over-year change of. This contributed to the annual value of -4,130.10% for FY2022, which is 385774.00% down from last year.
  • Latest data reveals that SELLAS Life Sciences Group reported Net Margin of -1,673.50% as of Q1 2022, which was down 589.28% from -242.79% recorded in Q2 2021.
  • Over the past 5 years, SELLAS Life Sciences Group's Net Margin peaked at -42.16% during Q1 2021, and registered a low of -1,673.50% during Q1 2022.
  • For the 3-year period, SELLAS Life Sciences Group's Net Margin averaged around -538.51%, with its median value being -219.18% (2020).
  • Data for SELLAS Life Sciences Group's Net Margin shows a maximum YoY slumped of 163,134bps (in 2022) over the last 5 years.
  • Over the past 3 years, SELLAS Life Sciences Group's Net Margin (Quarterly) stood at -195.58% in 2020, then reached -242.79% in 2021, then plummeted by 163,134bps to -1,673.50% in 2022.
  • Its Net Margin stands at -1,673.50% for Q1 2022, versus -242.79% for Q2 2021 and -42.16% for Q1 2021.